Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Inhibikase Therapeutics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a 298.01% increase from the last price of 2.01.
High | 298.0% | 8.00 |
Med | 298.0% | 8.00 |
Low | 148.8% | 5.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 31, 2025.
Average growth rate | +5.66% |
Average growth rate | +14.24% |
More ▼
Revenue history & estimates in USD
Average growth rate | -25.00% |
Average growth rate | +7.67% |
More ▼